Thank you and good bye. Hey any chance you could take dk3845 with you?
Sorry Fab, when I posted earlier I did not realize the OP was you. I do have, with a grain of salt, some respect for your opinion. Why do you feel a partner is a problem? I always felt a partner would bring a ton of up front cash to a very small market cap company. I am actually in this for the partner.
PS- Nice call on IDRA, found it from your posts and had a nice run last week. You think it is just taking a break?
We are going to get a lot of people that pile on because of the ODD news, but you are very correct THE PARTNER is the kicker and when that hits I will get out with a nice profit.
You really shouldn't be investing in Bio's
FDA Orphan Drug Designation database listing for DARA entered after-hours 2-24-2014.
FDA Orphan Drug Designation listing for DARA entered after-hours 2-24-2014. You can go to FDA website and do a search to confirm.
Generic Name: (6-[4-Deoxy-4-[(2E,4E)-tetradecadienoylglycyl] amino-L-glyceroB-L-manno-heptopyranosyl]amino-9H-purine)
Trade Name: n/a
Date Designated: 02-21-2014
Orphan Designation: Parenteral treatment of painful, chronic, chemotherapy-induced peripheral neuropathy that is refractory to conventional analgesics
Orphan Designation Status: Designated
FDA Orphan Approval Status: Not FDA Approved for Orphan Indication
Sponsor: DARA BioSciences, Inc.
8601 Six Forks Road
Raleigh, NC 27615
The sponsor address listed is the last reported by the sponsor to OOPD.
Why in the world would he even consider answering you. You have been the most negative whining cry baby on this board.
Without any news between now and then definitely. And contrary to all of "The Mitch's" singing it will give any short opportunity to get out and not get caught in Mitch's supposed post split short squeeze.